As reported previously (Pilipenko et al., 2000) , the sequence contains two amino acid substitutions (T279A and K311R -underlined) in comparion to the original sequence reported for this protein (then known as Mpp1 -accession number NP_035249) (Nakagawa et al., 1997) . Supplementary Table S2 : DNA primers and templates used for the generation of Ebp1 expression constructs, truncated FMDV IRES constructs, ssRNA and dsRNA transcription and preparation of dsDNA samples. 5'-GTAGTAGCAGTAGGATCATGACGGGCGAAGACG-3'
Construct Primers
5'-GAGGGGACAAGCTTCAGTCCCCAGCTCC-3' 
.| EBP1 ------------------------------------------------------------
E.COLI ------------------------------------------------------------ PFU -----------------------------------------------------------
.| EBP1 KQHVIDGEKT IIQNPTDQQK KDHEK-AEF-EVHEVYAVDV LVSSGEGKAK -DAGQRTTIY 247 HUMAN GQYRIHAGKT VPIIK----G G--EATR-ME E-GEVYAIET FGSTGKGVVH DD--MECSHY 383 E.COLI GQ-GFHEEPQ VLHYD----S RE-TN-VVL-KPGMTFTIEP MVNAGKKEIR TM--KDG---220 PFU ERYKLHAGIS IPNIY----R PH-DN-YVL-KEGDVFAIEP FATIGAGQVI EV

.| EBP1 KRDPSKQYGL KMKTSRAFFS EVERRFDA---MPFTLRAFE DEKKARMGVV ECAKHELLQP 304 HUMAN MKNFDVGHVP IRLPRTKHLL NVINENFGTL AFCRRWLDRL GESKYLMALK NLCDLGIVDP 443 E.COLI ------------------------------------------------------------
.| EBP1 FNVLYEK-EG EFVAQFKFTV LLMPNGPMRI TSGPFEPDLY KSEMEVQDAE LKALLQSSAS 363 HUMAN YPPLCDIKG-SYTAQFEHTI LLRPTCKEVV SRGDDY------------------------478 E.COLI -WTVKTKDR-SLSAQYEHTI VVTDNGCEIL TLRKDDTIPA IISHDE--------------264 PFU YPVLKEIRN-GIVAQFEHTI IVEKDSVIVT TE-------------------------
.| . EBP1 RKTQKKKKKK ASKTVENATS GETLEENGAG D 394 HUMAN -------------------------------E.COLI -------------------------------PFU -------------------------------
PDB files for Ebp1, human p67MAP2 (1kq9), P. fu MAP (1xgs) and E. coli MAP (2mat) were submitted for multiple 3D Secondary Structure Matching (SSM) at http://www.ebi.ac.uk/msd-srv/ssm/. Aligned PDB files were visualised in Pymol and the identified secondary structure mapped on to the sequence alignment file generated by SSM. Alpha helices are shown in red, beta sheets in blue. Regions in grey were not present in the input PDB files. Both proteins were analysed by HPLC for their ability to remove the N-terminal Met from an octameric peptide substrate (MASKANQS), yielding the heptameric product (ASKANQS). The plasmid encoding a truncated but active form of hMAP2 (lacking residues 1-89) was kindly provided by Anthony Addlagatta and Brian Matthews (University of Oregon, USA). The protein was expressed and purified essentially as described (Addlagatta et al., 2005) . Methionine aminopeptidase assays were performed by incubating the protein at 4 µM with 300 µM peptide substrate at 25°C for 0, 6 and 24 hrs in a buffer composed of 10 mM HEPES (pH 7.5), 100 mM NaCl and 1mM CoCl 2 . Reaction volumes were 200 µL. At the end of the incubation 50 µL of the reaction mix was diluted with an equal volume of water and applied to an ACE 5 C18 reverse phase HPLC column (250x4.6 mm) (Hichrom Limited, Berckshire, UK). (A) The UV trace for the heptameric and octameric peptides in the absence of added protein at concentrations of peptide equal to those present in samples of the reaction solution. A trace showing the heptameric product in the presence of hMAP2 is also shown. (B) UV traces of samples taken at 0 hrs, 6 hrs and 24 hrs from an incubation of the octameric substrate with hMAP2 as described above. In the presence of 1 mM CoCl 2 cleavage is rapid, with a sharp decline in the substrate peak and a concomitant increase in the product peak at the earliest time point.
In the absence of added CoCl 2 no such change is observed. (C) UV traces of samples taken at 0 hrs, 6 hrs and 24 hrs from an incubation of the octameric substrate with full length Ebp1. Incubation with Ebp1 had no affect on the concentration of octameric substrate in the reaction even after 24 hr incubation. Similarly, no product peak is observed. 
Methods:
The IRES RNA samples were prepared by unlabelled in vitro transcription using the Promega RiboMAX kit following the manufacturers instructions. Following DNAseI digestion, RNA transcripts were purified using RNAeasy columns (Qiagen), precipitated using ethanol/sodium acetate and dissolved in RNase-free water to a concentration of 1.5 mg/ml. The RNA was annealed before use in binding experiments by heating to 70 °C for 5 minutes and slow-cooling to room temperature over 1 hr. Binding experiments were performed in 10 µL reaction volumes by mixing 100 ng of RNA (approx. 67 nM) with increasing concentrations of protein (0, 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 60 µM) dsDNA; of these different types of ligand, ssRNA appears to bind tightest.
Methods: RNA samples were prepared by in vitro transcription using the synthetic DNA templates and T7 primers detailed in Table S2 . Transcription reactions were performed using MEGAshortscript T7 kit (Ambion). DNaseI-treated RNA transcripts were purified on G25 microspin columns (GE Lifesciences) with a concentration 1 mg/ml. Transcription of the template for dsRNA yields a molecule with the sequence 
RNA binding domain (dsRBD).
σ 70 -like domains are predicted to adopt a helix-turn-helix motif (Wehner and Baserga, 2002) , similar to the structure observed in some DNA binding proteins, such as the lambda repressor whereas the dsRBD forms an autonomous αβββα-fold (Doyle and Jantsch, 2002) .
(A) Ribbon diagram of a single monomer of the Lambda repressor [ (Beamer and Pabo, 1992); PDB 1lmb] bound to DNA. The helix-turn-helix motif that binds in the major groove is shown in blue.
(B) A double-stranded RNA binding domain (green) bound to RNA [ (Ryter and Schultz, 1998) ; PDB 1di2].
(C) Structure of Ebp1. The portions of the structure that were predicted to contain RNA-binding domains composed of a σ 70 -like helix-turn-helix motif (Squatrito et al., 2004) or a dsRBD (Squatrito et al., 2006) are shown in blue and green respectively. It is clear from the structure that these sequences adopt quite different folds within Ebp1. In fact the primary RNA-binding domain maps to a Lys-rich sequence ( 361 SASRKTQKKKKKKAS 375 ) that lies immediately beyond the C-terminus of the construct that was crystallised.
